An Injectable Epigenetic Autophagic Modulatory Hydrogel for Boosting Umbilical Cord Blood NK Cell Therapy Prevents Postsurgical Relapse of Triple‐Negative Breast Cancer

Abstract Triple‐negative breast cancer (TNBC) exhibits resistance to conventional treatments due to the presence of cancer stem cells (CSCs), causing postsurgical relapse and a dismal prognosis. Umbilical cord blood natural killer (UCB‐NK) cell‐based immunotherapy represents a promising strategy for...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yihang Gong, Wenjie Chen, Xiuxing Chen, Yizhan He, Hua Jiang, Xijian Zhang, Lijie Pan, Beibei Ni, Fan Yang, Yan Xu, Qi Zhang, Lei Zhou, Yusheng Cheng
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2022-08-01
Series:	Advanced Science
Assuntos:	hydrogel sustained drug release TNBC UCB‐NK cell therapy wound healing
Acceso en liña:	https://doi.org/10.1002/advs.202201271
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!